Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page
- Check6 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedA site-wide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check20 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study record page now shows a 403 Forbidden error, indicating access to the page is blocked. This reflects a change in how the page is served (access restrictions) rather than an update to the study content.SummaryDifference20%

- Check69 days agoChange DetectedThe revision entry shows v3.6.6 replacing v3.6.5, indicating an updated publish/maintenance on the study details page. This update does not alter the displayed content or data.SummaryDifference0.1%

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.